William J Chase Buys $1M of Intellia Therapeutics Inc (NTLA) — SEC Form 4, Aug 22, 2025

Open-Market Net Purchase · SEC Form 4

+$1,003,000

Equity position changed by +288.2%

Reporting Owner

William J Chase

Director

TXN 2025-08-20 · FILED 2025-08-22

Equity Position 135K sh 34,693 → 134,693

Equity Change +288.2% shares held after vs before

Filing Lag 2 business days within 2-day SEC deadline

Form 4 · Statement of Changes in Beneficial Ownership

Intellia Therapeutics Inc

NTLA CIK 0001652130

Reporting Owner

Name	Relationship
William J Chase CIK 0001563572	Director

William J Chase at Intellia Therapeutics Inc Full insider history

Bought (12 mo) —

Sold (12 mo) —

More from this insider at Intellia Therapeutics Inc

Non-Derivative Securities Transactions

Title	Date	Type	Shares	Price	Net Total	Post-Txn	Ownership
Common StockF1 F2	2025-08-20	P - Purchase	100,000 A	$10.03	+$1,003,000	134,693	Direct

Footnotes (2)

F1: Reflects an open market purchase of shares of the Issuer's common stock by the Reporting Person in accordance with the Issuer's trading policies. Show more
F2: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.97 to $10.04, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares purchased by the reporting person on August 20, 2025 at each separate price. Show more

Institutional Holders

Largest by reported value

5%+ Holders · 13D/G 5 filers

Latest Schedule 13D/G per filer; stakes the filer reported closed are left out.

Other insiders at Intellia Therapeutics Inc

GET /v1/forms/4/0000950170-25-110979 API docs